GENE ONLINE|News &
Opinion
Blog

Special
64th ASH Annual Meeting and Exposition: Broad Coverage of Clinical, Social, and Nutritional Issues
2023-01-04
GeneOnline’s Pick: Top 10 New FDA-approved Drugs in 2022
2022-12-30
The FDA and Biogen Taking Heat for Aduhelm’s Approval Process
2022-12-30
64th ASH Annual Meeting and Exposition: Standard Treatments Face Challenges
2022-12-29
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
64th ASH Annual Meeting and Exposition: Discoveries That Reinvent Blood Disease Treatments
2022-12-20
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
MedTex Summit Asia 2022: Revolutionizing Smart Healthcare with Next Generation Technologies
2022-12-09
Moderna’s Personalized Cancer Therapy: The New Transformative Approach to Oncology
2022-12-08
European Commission Continues Fight with Illumina and Orders Grail Acquisition Divestment
2022-12-07
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05Partner
Spectrum to Cut 75% of Staff and NSCLC Program Following CLR
2022-11-28
BioFuture NYC 2022: Using Technology to Prepare for an Aging Population
2022-11-22
Illumina Genomics Forum Highlights – President Obama, Novel Sequencer, Bill Gates
2022-11-17Partner
1 2 3 4 5 17
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top